Ivan Dimov, Orca Bio CEO

Or­ca Bio's T cell ther­a­py may help blood can­cer pa­tients avoid trans­plant is­sues

Or­ca Bio on Mon­day said its T cell ther­a­py, when used in peo­ple with cer­tain blood can­cers, re­duced the risk of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.